Health Information Technology Advisory Committee Schedule of Meetings, 73862-73863 [2023-23762]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
73862
Federal Register / Vol. 88, No. 207 / Friday, October 27, 2023 / Notices
associated outpatient costs and charges,
but that have not yet registered in
OPAIS, to continue to use 340B drugs
for patients of the covered entity
pending registration of the facility in
OPAIS during the next 340B Program
quarterly registration period (January 1–
16). If a facility is not registered during
January 1–16 quarterly registration
period, the hospital covered entity may
be subject to audit and compliance
action.
2. HRSA will continue to allow offsite, outpatient facilities that are not yet
listed as a reimbursable facility on the
hospital’s most recently filed Medicare
Cost Report with associated outpatient
costs and charges to continue to use
340B drugs for patients of the covered
entity if the following conditions are
met:
a. The off-site, outpatient facility was
opened and began using 340B drugs
prior to the publication date of this
Notice; and
b. The hospital that is the covered
entity and the parent organization for
the off-site, outpatient facility provides
HRSA, via email to 340Bcompliance@
hrsa.gov within 90 days of publication
date of this Notice, with the following
information consistent with 340B
registration requirements:
• The name of the off-site, outpatient
facility;
• The date the site will be listed on
the hospital’s Medicare Cost Report (this
must be the next filed Medicare Cost
Report) with associated outpatient costs
and charges; and
• The date the covered entity will
register the site in OPAIS.
If a covered entity does not provide
this information within 90-days of
publication of this Notice, any off-site,
outpatient facility that is not listed on
the most recently filed Medicare Cost
Report with associated outpatient costs
and charges will have to cease
purchasing 340B drugs for use at those
facilities and will be subject to audit
and compliance action. Consistent with
longstanding 340B Program
requirements, covered entities that
provide this information within 90 days
of publication must subsequently
register in OPAIS at the soonest possible
opportunity (and no later than the dates
listed in the information provided to
HRSA), and recertify in OPAIS annually
with the most recently filed Medicare
Cost Report with associated outpatient
costs and charges.
3. Hospital covered entities using
340B drugs at off-site, outpatient
facilities that are not listed on the most
recently filed Medicare Cost Report with
associated outpatient cost and charges,
are not in OPAIS, and do not meet
VerDate Sep<11>2014
17:44 Oct 26, 2023
Jkt 262001
categories 1 or 2 above are out of
compliance and must stop using 340B
drugs at these unregistered sites as soon
as practically possible, but no later than
90 days after the publication of this
Federal Register Notice. After the 90-day
grace period, non-compliant covered
entities may be subject to audit and
compliance action. HRSA is allowing
for a 90-day grace period for affected
hospitals to come into compliance and
does not believe that any undue burden
would be caused by reverting back to its
original program guidelines, which have
been in place since 1994.
II. Other Deadlines
Deadlines for 340B Program
requirements other than those listed
above are not affected by this Notice. All
other registrations and change requests
are not affected by this Notice and will
be processed as they are received.
Carole Johnson,
Administrator.
[FR Doc. 2023–23702 Filed 10–26–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Information Technology
Advisory Committee Schedule of
Meetings
Office of the National
Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
AGENCY:
The Health Information
Technology Advisory Committee
(HITAC) was established in accordance
with the 21st Century Cures Act and the
Federal Advisory Committee Act. The
HITAC, among other things, identifies
priorities for standards adoption and
makes recommendations to the National
Coordinator for Health Information
Technology (National Coordinator). The
HITAC will hold public meetings for the
remainder of 2023 and throughout 2024.
See list of public meetings below.
FOR FURTHER INFORMATION CONTACT:
Michael Berry, Designated Federal
Officer, at Michael.Berry@hhs.gov, (202)
701–0795.
SUPPLEMENTARY INFORMATION: Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. app.), which
sets forth standards for the formation
and use of federal advisory committees.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Composition: The HITAC is
comprised of at least 25 members, of
which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives;
• Other members are appointed by
the Comptroller General of the United
States.
Members serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay
but will be provided per-diem and
travel costs for committee services, if
warranted.
Recommendations: The HITAC
recommendations to the National
Coordinator are publicly available at
https://www.healthit.gov/topic/federaladvisory-committees/recommendationsnational-coordinator-health-it.
Public Meetings: All HITAC meetings
will be virtual. Please note that some
HITAC meetings may also have an inperson meeting option. For web
conference instructions and the most
up-to-date information, including inperson meeting location (if applicable),
please visit the HITAC calendar on the
ONC website, www.healthit.gov/topic/
federal-advisory-committees/hitaccalendar.
The schedule of remaining meetings
to be held in 2023 and throughout 2024
is as follows:
• November 9, 2023, from
approximately 9:30 a.m. to 4:00 p.m./
Eastern Time (virtual and in-person
meeting options, address: Hubert H.
Humphrey Federal Building, 200
Independence Ave SW, Washington,
DC 20201)
• January 18, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• February 8, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• March 7, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• April 11, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
E:\FR\FM\27OCN1.SGM
27OCN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 207 / Friday, October 27, 2023 / Notices
• May 16, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• June 13, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• July 11, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• August 15, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• September 12, 2024, from
approximately 10:00 a.m. to 3:00
p.m./Eastern Time
• October 17, 2024, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• November 7, 2024, from
approximately 10:00 a.m. to 3:00
p.m./Eastern Time
All meetings are open to the public.
Additional meetings may be scheduled
as needed.
Contact Person for Meetings: Michael
Berry, Michael.Berry@hhs.gov. A notice
in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Michael
Berry for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, patient access, and use of
technologies that support public health.
In addition, the committee will also
address any administrative matters and
hear periodic reports from ONC. ONC
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ONC is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available on ONC’s website
after the meeting, at www.healthit.gov/
hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
public comment period, ONC will take
written comments after the meeting.
ONC welcomes the attendance of the
public at its HITAC meetings. If you
require special accommodations due to
a disability, please contact Michael
Berry at least seven (7) days in advance
of the meeting.
VerDate Sep<11>2014
17:44 Oct 26, 2023
Jkt 262001
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. 92–463, 5 U.S.C., app. 2).
Dated: October 16, 2023.
Michael Berry,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2023–23762 Filed 10–26–23; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Diversity Training Grants.
Date: December 1, 2023.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific
Review Officer, Office of Scientific Review/
DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208–S, Bethesda, MD
20892, (301) 435–0270, sun.saret@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 23, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23751 Filed 10–26–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
73863
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Minority Health and Health
Disparities.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocast at
the following link: https://
videocast.nih.gov/.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: February 1, 2024.
Closed: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: February 2, 2024.
Open: 11:00 a.m. to 5:00 p.m.
Agenda: Opening Remarks, Administrative
Matters, Director’s Report, Presentations, and
Other Business of the Council.
Place: National Institutes of Health, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Paul Cotton, Ph.D., RDN,
Director, Office of Extramural Research
Activities, National Institute on Minority
Health and Health Disparities, National
Institutes of Health, 6707 Democracy
Boulevard, Suite 800, Bethesda, MD 20892,
301–402–1366, paul.cotton@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
E:\FR\FM\27OCN1.SGM
27OCN1
]]>Agencies
[Federal Register Volume 88, Number 207 (Friday, October 27, 2023)]
[Notices]
[Pages 73862-73863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23762]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Information Technology Advisory Committee Schedule of
Meetings
AGENCY: Office of the National Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
-----------------------------------------------------------------------
SUMMARY: The Health Information Technology Advisory Committee (HITAC)
was established in accordance with the 21st Century Cures Act and the
Federal Advisory Committee Act. The HITAC, among other things,
identifies priorities for standards adoption and makes recommendations
to the National Coordinator for Health Information Technology (National
Coordinator). The HITAC will hold public meetings for the remainder of
2023 and throughout 2024. See list of public meetings below.
FOR FURTHER INFORMATION CONTACT: Michael Berry, Designated Federal
Officer, at [email protected], (202) 701-0795.
SUPPLEMENTARY INFORMATION: Section 4003(e) of the 21st Century Cures
Act (Pub. L. 114-255) establishes the Health Information Technology
Advisory Committee (referred to as the ``HITAC''). The HITAC will be
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended, (5 U.S.C. app.), which sets forth
standards for the formation and use of federal advisory committees.
Composition: The HITAC is comprised of at least 25 members, of
which:
No fewer than 2 members are advocates for patients or
consumers of health information technology;
3 members are appointed by the HHS Secretary
[cir] 1 of whom shall be appointed to represent the Department of
Health and Human Services and
[cir] 1 of whom shall be a public health official;
2 members are appointed by the majority leader of the
Senate;
2 members are appointed by the minority leader of the
Senate;
2 members are appointed by the Speaker of the House of
Representatives;
2 members are appointed by the minority leader of the
House of Representatives;
Other members are appointed by the Comptroller General of
the United States.
Members serve for one-, two-, or three-year terms. All members may
be reappointed for a subsequent three-year term. Each member is limited
to two three-year terms, not to exceed six years of service. Members
serve without pay but will be provided per-diem and travel costs for
committee services, if warranted.
Recommendations: The HITAC recommendations to the National
Coordinator are publicly available at https://www.healthit.gov/topic/federal-advisory-committees/recommendations-national-coordinator-health-it.
Public Meetings: All HITAC meetings will be virtual. Please note
that some HITAC meetings may also have an in-person meeting option. For
web conference instructions and the most up-to-date information,
including in-person meeting location (if applicable), please visit the
HITAC calendar on the ONC website, www.healthit.gov/topic/federal-advisory-committees/hitac-calendar.
The schedule of remaining meetings to be held in 2023 and
throughout 2024 is as follows:
November 9, 2023, from approximately 9:30 a.m. to 4:00 p.m./
Eastern Time (virtual and in-person meeting options, address: Hubert H.
Humphrey Federal Building, 200 Independence Ave SW, Washington, DC
20201)
January 18, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
February 8, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
March 7, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
April 11, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
[[Page 73863]]
May 16, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
June 13, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
July 11, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
August 15, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
September 12, 2024, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
October 17, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
November 7, 2024, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
All meetings are open to the public. Additional meetings may be
scheduled as needed.
Contact Person for Meetings: Michael Berry, [email protected].
A notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Please email
Michael Berry for the most current information about meetings.
Agenda: As outlined in the 21st Century Cures Act, the HITAC will
develop and submit recommendations to the National Coordinator on the
topics of interoperability, privacy and security, patient access, and
use of technologies that support public health. In addition, the
committee will also address any administrative matters and hear
periodic reports from ONC. ONC intends to make background material
available to the public no later than 24 hours prior to the meeting
start time. If ONC is unable to post the background material on its
website prior to the meeting, the material will be made publicly
available on ONC's website after the meeting, at www.healthit.gov/hitac.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person prior to the
meeting date. An oral public comment period will be scheduled at each
meeting. Time allotted for each commenter will be limited to three
minutes. If the number of speakers requesting to comment is greater
than can be reasonably accommodated during the scheduled public comment
period, ONC will take written comments after the meeting.
ONC welcomes the attendance of the public at its HITAC meetings. If
you require special accommodations due to a disability, please contact
Michael Berry at least seven (7) days in advance of the meeting.
Notice of these meetings are given under the Federal Advisory
Committee Act (Pub. L. 92-463, 5 U.S.C., app. 2).
Dated: October 16, 2023.
Michael Berry,
Designated Federal Officer, Office of the National Coordinator for
Health Information Technology.
[FR Doc. 2023-23762 Filed 10-26-23; 8:45 am]
BILLING CODE 4150-45-P
